newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results

●Q3 Revenue of $12.3 million; a $3.2M and 35% increase year-over-year ●Q3 Test volume up 26% year over year to record levels ●Q3 Cash collections of $11.3M; a $1.4M and 15% increase year-over-year ●Q3 Volume, Revenue,